Authors:
Capiluppi, B
Ciuffreda, D
Quinzan, GP
Sciandra, M
Marroni, M
Morandini, B
Costigliola, P
Guerra, L
Di Pietro, M
Fibbia, GF
Visona, R
Cusini, M
Bressi, C
Tambussi, G
Lazzarin, A
Citation: B. Capiluppi et al., Four drug-HAART in primary HIV-1 infection: clinical benefits and virologic parameters, J BIOL REG, 14(1), 2000, pp. 58-62
Authors:
Cusini, M
Cusan, M
Parolin, C
Sciocatti, L
Decleva, I
Mengoli, C
Suligoi, B
Palu, G
Citation: M. Cusini et al., Seroprevalence of herpes simplex virus type 2 infection among attendees ofa sexually transmitted disease clinic in Italy, SEX TRA DIS, 27(5), 2000, pp. 292-295
Authors:
Gambini, D
Decleva, I
Lupica, L
Ghislanzoni, M
Cusini, M
Alessi, E
Citation: D. Gambini et al., Mycoplasma genitalium in males with nongonococcal urethritis - Prevalence and clinical efficacy of eradication, SEX TRA DIS, 27(4), 2000, pp. 226-229
Authors:
Brambilla, A
Villa, C
Rizzardi, G
Veglia, F
Ghezzi, S
Lazzarin, A
Cusini, M
Muratori, S
Santagostino, E
Gringeri, A
Louie, LG
Sheppard, HW
Poli, G
Michael, NL
Pantaleo, G
Vicenzi, E
Citation: A. Brambilla et al., Shorter survival of SDF1-3 ' Al3 ' A homozygotes linked to CD4(+) T cell decrease in advanced human immunodeficiency virus type I infection, J INFEC DIS, 182(1), 2000, pp. 311-315
Authors:
Gringeri, A
Musicco, M
Hermans, P
Bentwich, Z
Cusini, M
Bergamasco, A
Santagostino, E
Burny, A
Bizzini, B
Zagury, D
Citation: A. Gringeri et al., Active anti-interferon-alpha immunization: A European-Israeli, randomized,double-blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (the EURIS study), J ACQ IMM D, 20(4), 1999, pp. 358-370